Search all trials

Find therapies in clinical trials near you – page 8

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Type 2 diabetes mellitus

Not yet recruiting

Registered drug

Efficacy and Safety of Alogliptin Plus Empagliflozin Compared with Alogliptin Alone or Empagliflozin Alone in Adults with Type 2 Diabetes on Metformin

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Alogliptin

Contact Research Centre

Aortic valve stenosis

Not yet recruiting

Investigational

A Phase 2b/3 Randomized Double‑Blind Study of Ataciguat to Slow Disease Progression in Adults with Moderate Calcific Aortic Valve Stenosis

Investigational

Portugal

Participants:18–64 years · 65+ years

Contact Research Centre

Hidradenitis

Not yet recruiting

Investigational

Long-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:Remibrutinib

Contact Research Centre

Psoriatic arthropathy

Not yet recruiting

InvestigationalNo placebo

A study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis

InvestigationalNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Sonelokimab

Contact Research Centre

Parkinson's disease

Not yet recruiting

Registered drug

A study to test if BHV-8000 is effective and safe for adults with early Parkinson's disease

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Ioflupane (123I)

Contact Research Centre

Arteriosclerosis

Not yet recruiting

Investigational

Study of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

Investigational

Portugal

Participants:18–64 years · 65+ years

Contact Research Centre

Myasthenia gravis

Not yet recruiting

Investigational

Efficacy and Safety of DNTH103 in Adults with Generalized Myasthenia Gravis: A Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:Dnth103

Contact Research Centre

Idiopathic pulmonary fibrosis

Not yet recruiting

Registered drugNo placebo

Randomized Phase 3 Study of Deupirfenidone (LYT‑100) versus Pirfenidone in Adults with Idiopathic Pulmonary Fibrosis

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Deupirfenidone

Contact Research Centre

Plasma cell myeloma

Not yet recruiting

Registered drugNo placebo

Ramantamig (JNJ-79635322) with drug combination versus standard therapy in newly diagnosed multiple myeloma patients not eligible for stem cell transplant

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Neoplasm

Not yet recruiting

Registered drugNo placebo

Phase 1/2 Study of ter-2013-01, imlunestrant, and fulvestrant in patients with solid tumors with AKT/PI3K/PTEN pathway alterations

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Fulvestrant

Contact Research Centre

Focal segmental glomerulosclerosis

Not yet recruiting

Registered drug

Efficacy and Safety of Pegcetacoplan in Adults and Adolescents with Focal Segmental Glomerulosclerosis: Phase 2/3 Open‑Label and Randomized Placebo‑Controlled Study

Registered drug

Portugal

Participants:0–17 years · 18–64 years · 65+ years
Substances:Pegcetacoplan

Contact Research Centre

Urinary tract infection

Not yet recruiting

Registered drug

MV140 for Women with Recurrent Uncomplicated Urinary Tract Infections

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Ascorbic Acid

Contact Research Centre

Find therapies in clinical trials near you – page 8

207 trials match your criteria

Type 2 diabetes mellitus

Efficacy and Safety of Alogliptin Plus Empagliflozin Compared with Alogliptin Alone or Empagliflozin Alone in Adults with Type 2 Diabetes on Metformin

Aortic valve stenosis

A Phase 2b/3 Randomized Double‑Blind Study of Ataciguat to Slow Disease Progression in Adults with Moderate Calcific Aortic Valve Stenosis

Hidradenitis

Long-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa

Psoriatic arthropathy

A study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis

Parkinson's disease

A study to test if BHV-8000 is effective and safe for adults with early Parkinson's disease

Arteriosclerosis

Study of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

Myasthenia gravis

Efficacy and Safety of DNTH103 in Adults with Generalized Myasthenia Gravis: A Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study

Idiopathic pulmonary fibrosis

Randomized Phase 3 Study of Deupirfenidone (LYT‑100) versus Pirfenidone in Adults with Idiopathic Pulmonary Fibrosis

Plasma cell myeloma

Ramantamig (JNJ-79635322) with drug combination versus standard therapy in newly diagnosed multiple myeloma patients not eligible for stem cell transplant

Neoplasm

Phase 1/2 Study of ter-2013-01, imlunestrant, and fulvestrant in patients with solid tumors with AKT/PI3K/PTEN pathway alterations

Focal segmental glomerulosclerosis

Efficacy and Safety of Pegcetacoplan in Adults and Adolescents with Focal Segmental Glomerulosclerosis: Phase 2/3 Open‑Label and Randomized Placebo‑Controlled Study

Urinary tract infection

MV140 for Women with Recurrent Uncomplicated Urinary Tract Infections

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.